UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 78

Sortiert nach

International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials

American journal of respiratory and critical care medicine, 2022-07, Vol.206 (1), p.25-33

2022

Link zum Volltext

Verfügbarkeit prüfen

Cigarette smoking and response to inhaled corticosteroids in COPD

The European respiratory journal, 2018-01, Vol.51 (1), p.1701393-1701393

2018

Link zum Volltext

Verfügbarkeit prüfen

Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD

Respiratory research, 2019-05, Vol.20 (1), p.86-86, Article 86

2019

Link zum Volltext

Verfügbarkeit prüfen

Accuracy of self-reported smoking status in first trimester aneuploidy screening

Prenatal diagnosis, 2013-03, Vol.33 (3), p.245-250

2013

Link zum Volltext

Verfügbarkeit prüfen

Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial

ERJ open research, 2021-07, Vol.7 (3), p.902

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review

American journal of respiratory and critical care medicine, 2021-03, Vol.203 (6), p.689-698

2021

Link zum Volltext

Verfügbarkeit prüfen

Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease

Journal of the American College of Cardiology, 2018-09, Vol.72 (10), p.1126-1137

2018

Link zum Volltext

Verfügbarkeit prüfen

Reply to Fisk and Wilkinson: Aortic Pulse Wave Velocity Predicts All-Cause Mortality in Chronic Obstructive Pulmonary Disease

American journal of respiratory and critical care medicine, 2020-07, Vol.202 (1), p.149-150

2020

Link zum Volltext

Verfügbarkeit prüfen

First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system

Prenatal diagnosis, 2007-03, Vol.27 (3), p.264-271

2007

Link zum Volltext

Verfügbarkeit prüfen

Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia

Prenatal diagnosis, 2008-01, Vol.28 (1), p.7-10

2008

Link zum Volltext

Verfügbarkeit prüfen

Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction

American journal of respiratory and critical care medicine, 2017-04, Vol.195 (7), p.881-888

2017

Link zum Volltext

Verfügbarkeit prüfen

Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial

European heart journal, 2018-09, Vol.39 (33), p.3128-3134

2018

Link zum Volltext

Verfügbarkeit prüfen

The association between gestational diabetes mellitus and first trimester aneuploidy screening markers

Annals of clinical biochemistry, 2013-11, Vol.50 (Pt 6), p.603

2013

Link zum Volltext

Verfügbarkeit prüfen

Impact of pre-enrolment medication use on clinical outcomes in SUMMIT

ERJ open research, 2019-02, Vol.5 (1), p.203

2019

Link zum Volltext

Verfügbarkeit prüfen

ADAM12s in maternal serum as a potential marker of pre-eclampsia

Prenatal diagnosis, 2008-03, Vol.28 (3), p.212-216

2008

Link zum Volltext

Verfügbarkeit prüfen

Pulse Wave Velocity in Chronic Obstructive Pulmonary Disease and the Impact of Inhaled Therapy (SUMMIT): A Randomized Double-Blind Clinical Trial

American journal of respiratory and critical care medicine, 2020-05, Vol.201 (10), p.1307-1310

2020

Link zum Volltext

Verfügbarkeit prüfen

FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease

International journal of chronic obstructive pulmonary disease, 2020-01, Vol.15, p.1135-1142

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of gestational age on first trimester maternal serum prenatal screening correction factors for ethnicity and IVF conception

Prenatal diagnosis, 2013-01, Vol.33 (1), p.56-60

2013

Link zum Volltext

Verfügbarkeit prüfen

First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk

Prenatal diagnosis, 2009-08, Vol.29 (8), p.781-789

2009

Link zum Volltext

Verfügbarkeit prüfen

First trimester maternal serum placental growth factor levels in twin pregnancies

Prenatal diagnosis, 2013-12, Vol.33 (13), p.1260-1263

2013

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a dried blood spot assay to measure prenatal screening markers pregnancy-associated plasma protein a and free β-subunit of human chorionic gonadotropin

Clinical chemistry (Baltimore, Md.), 2013-06, Vol.59 (6), p.968-975

2013

Link zum Volltext

Verfügbarkeit prüfen

Correction of first trimester biochemical aneuploidy screening markers for smoking status: influence of gestational age, maternal ethnicity and cigarette dosage

Prenatal diagnosis, 2013-02, Vol.33 (2), p.116-123

2013

Link zum Volltext

Verfügbarkeit prüfen

Regional differences in rate of FEV 1 decline in COPD: lessons from SUMMIT

The European respiratory journal, 2019-06, Vol.53 (6), p.1900278

2019

Link zum Volltext

Verfügbarkeit prüfen

HIGH-SENSITIVITY CARDIAC TROPONIN I AND RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH COPD AND HEIGHTENED CARDIOVASCULAR RISK: A BIOMARKER SUB-STUDY OF THE SUMMIT TRIAL

Journal of the American College of Cardiology, 2017-03, Vol.69 (11), p.1819-1819

2017

Link zum Volltext

Verfügbarkeit prüfen

First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes

Prenatal diagnosis, 2008-02, Vol.28 (2), p.121-125

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(78)

Sprache

Englisch
(78)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(64)
Humans
(63)
Life Sciences & Biomedicine
(62)
Female
(49)
Pregnancy
(33)
Genetics & Heredity
(31)
Obstetrics & Gynecology
(31)
Adult
(29)
Biological And Medical Sciences
(25)
Gynecology. Andrology. Obstetrics
(25)
Medical Sciences
(25)
Male
(23)
Biomarkers - Blood
(21)
Fundamental And Applied Biological Sciences. Psychology
(19)
Genetics Of Eukaryotes. Biological And Molecular Evolution
(18)
Aneuploidy
(17)
Molecular And Cellular Biology
(17)
Papp-A
(17)
Delivery. Postpartum. Lactation
(16)
Aged
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials

Cigarette smoking and response to inhaled corticosteroids in COPD

Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD

Accuracy of self-reported smoking status in first trimester aneuploidy screening

Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial

Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review

Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease

Reply to Fisk and Wilkinson: Aortic Pulse Wave Velocity Predicts All-Cause Mortality in Chronic Obstructive Pulmonary Disease

First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system

Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia

Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction

Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial

The association between gestational diabetes mellitus and first trimester aneuploidy screening markers

Impact of pre-enrolment medication use on clinical outcomes in SUMMIT

ADAM12s in maternal serum as a potential marker of pre-eclampsia

Pulse Wave Velocity in Chronic Obstructive Pulmonary Disease and the Impact of Inhaled Therapy (SUMMIT): A Randomized Double-Blind Clinical Trial

FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease

Effect of gestational age on first trimester maternal serum prenatal screening correction factors for ethnicity and IVF conception

First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk

First trimester maternal serum placental growth factor levels in twin pregnancies

Evaluation of a dried blood spot assay to measure prenatal screening markers pregnancy-associated plasma protein a and free β-subunit of human chorionic gonadotropin

Correction of first trimester biochemical aneuploidy screening markers for smoking status: influence of gestational age, maternal ethnicity and cigarette dosage

Regional differences in rate of FEV 1 decline in COPD: lessons from SUMMIT

HIGH-SENSITIVITY CARDIAC TROPONIN I AND RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH COPD AND HEIGHTENED CARDIOVASCULAR RISK: A BIOMARKER SUB-STUDY OF THE SUMMIT TRIAL

First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes

Suchergebnisse filtern